CPX was crushed on Friday by blind shorting
stock was down -$4/shr but today BMO Capital defends CPX and maintains $38 target.
Complete Production weakness provides attractive entry point, says BMO Capital
After Complete Production reported lower than expected Q4 operating EPS, BMO Capital believes that the miss reflects higher costs and lower margins primarily caused by timing issues.
The firm believes that the company will still deliver solid earnings growth and it maintains a $38 target and Outperform rating.